GLAUKOS CORP
GKOSNYSE🏆 #785 by market capEarnings Oct 28US Equity
$181.43▲ $0.25 (+0.14%)
🌙 After hours$213.38▲ 17.61%Regular close · extended-hours price shownTrack GKOS
Get earnings, price moves & breaking news on Telegram
24h▲ 0.1%
7d▲ 2.5%
14d▲ 9.4%
30d▲ 14.5%
ytd▲ 60.8%
1y▲ 135.9%
🏦Market Cap
$10.70B
Mid Cap
📈Revenue Growth (YoY)
41.5%
High Growth
📊Gross Margin
79.1%
High
💵FCF Margin
2.6%
Thin
⚖️P/S Ratio
17.4x
Expensive
Otter Score
68
Fair
GLAUKOS CORP
GKOSAnalyst Ratings
Price
$181.43
Total
25
Raised
2
Lowered
1
Avg PT
$192.90
H / L
$215 / $150
| Institution | Action | Rating | Date | Upside | |
|---|---|---|---|---|---|
BTIG | Reiterated | Buy | 2026-10-12 | $205.00 | +13.00% |
Jefferies | Reiterated | Buy | 2026-09-22 | $210.00 | +15.70% |
Wells Fargo | Reiterated | Overweight | 2026-07-30 | $178.00 | −1.90% |
Truist Securities | Reiterated | Buy | 2026-07-30 | — | — |
Stifel | Reiterated | Buy | 2026-07-30 | — | — |
Citigroup | Reiterated | Buy | 2026-07-30 | — | — |
Needham | Reiterated | Buy | 2026-07-30 | $201.00 | +10.80% |
Piper Sandler | Reiterated | Overweight | 2026-07-30 | $195.00 | +7.50% |
UBS | Reiterated | Neutral | 2026-07-30 | $150.00 | −17.30% |
HC Wainwright & Co. | Reiterated | Buy | 2026-07-30 | — | — |
JP Morgan | Reiterated | Overweight | 2026-04-30 | $42.00 | −76.90% |
Stephens & Co. | Reiterated | Overweight | 2026-01-02 | — | — |
Morgan Stanley | Reiterated | Underweight | 2025-05-06 | $120.00 | −33.90% |
Mizuho | Reiterated | Outperform | 2025-04-16 | — | — |
William Blair | Upgraded | Market Perform → Outperform | 2022-02-03 | — | — |
Oppenheimer | Downgraded | Outperform → Perform | 2021-07-14 | — | — |
Stifel Nicolaus | Reiterated | Hold | 2020-02-28 | $190.00 | +4.70% |
Berenberg | Upgraded | Hold → Buy | 2020-01-06 | — | — |
BMO Capital | Reiterated | Market Perform | 2019-05-09 | — | — |
BTIG Research | Reiterated | Neutral | 2019-03-08 | — | — |
Roth Capital | Reiterated | Buy | 2016-08-02 | — | — |
Cantor Fitzgerald | Reiterated | Buy | 2016-06-02 | — | — |
PiperJaffray | Reiterated | Overweight | 2016-02-09 | — | — |
Canaccord Genuity | Reiterated | Buy | 2015-07-20 | — | — |
Goldman Sachs | Reiterated | Neutral | 2015-07-20 | $138.00 | −23.90% |
Institution
BTIG
Reiterated · Buy · 2026-10-12
$205.00
+13.00%
Jefferies
Reiterated · Buy · 2026-09-22
$210.00
+15.70%
Wells Fargo
Reiterated · Overweight · 2026-07-30
$178.00
−1.90%
Truist Securities
Reiterated · Buy · 2026-07-30
—
—
Stifel
Reiterated · Buy · 2026-07-30
—
—
Citigroup
Reiterated · Buy · 2026-07-30
—
—
Needham
Reiterated · Buy · 2026-07-30
$201.00
+10.80%
Piper Sandler
Reiterated · Overweight · 2026-07-30
$195.00
+7.50%
UBS
Reiterated · Neutral · 2026-07-30
$150.00
−17.30%
HC Wainwright & Co.
Reiterated · Buy · 2026-07-30
—
—
JP Morgan
Reiterated · Overweight · 2026-04-30
$42.00
−76.90%
Stephens & Co.
Reiterated · Overweight · 2026-01-02
—
—
Morgan Stanley
Reiterated · Underweight · 2025-05-06
$120.00
−33.90%
Mizuho
Reiterated · Outperform · 2025-04-16
—
—
William Blair
Upgraded · Market Perform → Outperform · 2022-02-03
—
—
Oppenheimer
Downgraded · Outperform → Perform · 2021-07-14
—
—
Stifel Nicolaus
Reiterated · Hold · 2020-02-28
$190.00
+4.70%
Berenberg
Upgraded · Hold → Buy · 2020-01-06
—
—
BMO Capital
Reiterated · Market Perform · 2019-05-09
—
—
BTIG Research
Reiterated · Neutral · 2019-03-08
—
—
Roth Capital
Reiterated · Buy · 2016-08-02
—
—
Cantor Fitzgerald
Reiterated · Buy · 2016-06-02
—
—
PiperJaffray
Reiterated · Overweight · 2016-02-09
—
—
Canaccord Genuity
Reiterated · Buy · 2015-07-20
—
—
Goldman Sachs
Reiterated · Neutral · 2015-07-20
$138.00
−23.90%
One row per institution · price target from the firm's latest published target